Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    DENIVOS study page now renders a 403 Forbidden error, replacing the usual detailed study information with an error view. The content sections such as history, eligibility criteria, and outcome measures are no longer visible.
    Difference
    17%
    Check dated 2026-09-20T19:41:56.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A funding attribution for 2018 (NIH grant/contract) was added, and the page revision label was updated from v3.6.5 to v3.6.6 to reflect the current version.
    Difference
    0.1%
    Check dated 2026-08-30T06:44:38.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The revision marker at the bottom was updated from v3.6.4 to v3.6.5, signaling a maintenance update to the Study Details page. This change reflects a small backend or content refresh rather than a substantive change to the trial information.
    Difference
    0.0%
    Check dated 2026-08-08T23:49:56.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a recent site update without changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T12:46:16.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.2 to v3.6.3, reflecting an updated version of the page content.
    Difference
    0.0%
    Check dated 2026-07-03T23:17:46.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The study page now shows revision v3.6.2, replacing v3.6.0, indicating a minor, non-content update to how the page is rendered or tracked.
    Difference
    0.0%
    Check dated 2026-06-26T23:59:33.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.